SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) — The shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistula.com) investigates whether Invivyd, Inc. (“Invivyd” or the “Company”) IVVD (formerly called Adagio), one of its officers or others has violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they can be recovered under federal securities laws.

What happens if I bought Invivyd common stock? If you bought Invivyd common stock and suffered significant losses on your investment, join our investigation now:

Click or paste the following web address into your browser to submit your losses:

https://www.johnsonfistel.com/investigations/invivyd-ivvd-adagio-ipo-class-action

Or contact Jim Baker at for more information [email protected] or (619) 814-4471

There are no costs or obligations for you.

What does Johnson examine fistula? On or about August 10, 2021, Adagio/Invivyd completed its initial public offering (“IPO”) and the Company sold 20.9 million shares for $17.00. Since the IPO, the stock has plummeted and on October 3, 2022, Invivyd stock closed at $3.24.

Specifically, Johnson Fistel’s investigation aims to determine whether the company’s filings with the Securities and Exchange Commission related to its August 2021 IPO and subsequent communications to investors contained false statements of material facts or omitted other facts , which are necessary to refute the statements contained therein misleading in relation to the business and operations of the company.

What if I have relevant non-public information? Those with nonpublic information about the company should consider cooperating with our investigation or participating in the SEC’s whistleblower program. Under the SEC program, whistleblowers who provide original information can, under certain circumstances, receive rewards of up to thirty percent of their…